Announcements

6 August 2026
Meet Us at the ESMO Congress 2026, 23–27 October 2026, Madrid, Spain


The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.

The following open access journals will be represented at this conference:

If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #P8097 and answering any questions that you may have.

For more information about this conference, please visit the following website:

https://www.esmo.org/meeting-calendar/esmo-congress-2026.

5 August 2026
MDPI INSIGHTS: The CEO’s Letter #37 – Canada Summit, Sciforum Relaunch, 30 Years of Impactful Research & ISPRS 2026

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from the MDPI Canada Summit 2026 in Toronto (9–10 July)

As part of this year’s MDPI Summit events, we were delighted to host Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) in Toronto for the MDPI Canada Summit 2026 this July.

Across the two days, we presented on topics including research integrity, editorial leadership, artificial intelligence, peer review, and the evolving role of the EiC. More importantly, the Summit created space for feedback and conversations with the academic community: these engagements continue play and important role in shaping how MDPI develops its journals and services.

Why Canada?

Canada has become one of the world’s leading Open Access (OA) nations. In 2025, 68% of Canadian research publications were published OA, with more than 73,000 OA articles produced during the year. Over the past five years alone, Canadian researchers have published more than 526,000 scholarly articles, showing both the scale and quality of Canadian research.

MDPI Toronto Office

“Canada has become one of the world’s leading Open Access nations”

Since opening in 2019, our Toronto office has grown to more than 85 colleagues supporting editorial operations, research integrity, marketing, societies, conferences, indexing, author services, and many other functions across North America. It was great to spend time with the team, see first-hand the energy and enthusiasm they bring to their work, and recognize the significant role they play in building relationships with the Canadian research community and delivering events such as this Summit.

MDPI and Canada

Today, Canada is an important part of the MDPI community:

  • More than 53,800 articles from Canadian institutions published with MDPI since 1996
  • More than 5,800 MDPI publications from Canadian researchers in 2025
  • Nearly 1,900 Canadian Editorial Board Members, including 24 Editors-in-Chief; 49 Section Editors-in-Chief
  • More than 30 Institutional Open Access Partnerships (IOAP) with universities across Canada

“The academic community is at the center of everything we do”

These numbers reflect the long-term partnerships with researchers, reviewers, editors, and institutions who continue to place their trust in MDPI.

Summit Program

Throughout the Summit, we presented and discussed topics against the following agenda:

  • MDPI at 30: Introduction, Reflections and the Road Ahead – Stefan Tochev (CEO)
  • Engagement with Academic Community and Society Partnerships – Karen Irwin (Associate Editorial Engagement Manager) and Carla Aloè (Head of Societies and Acquisition)
  • Latest Developments in the Editorial Process – Summer Huggard (Operations Manager)
  • Research Integrity and Publication Ethics – Renato Merki (Research Integrity Specialist)
  • AI and Technology in Publishing – Dr. Barnaby Crook (Regional Engagement Editor)
  • Panel Discussion – Bob Vrooman (Head of Business Development / Operations Manager, USA), Summer Huggard, Renato Merki, and myself

These presentations reinforce something we often say at MDPI: The academic community is at the center of everything we do. Each session concluded with a Q&A, allowing for discussions throughout the Summit to engage directly with our EiCs and EBMs.

Further Reading

I also had the opportunity to be interviewed by University Affairs about the evolving landscape of scholarly publishing, Open Access, and the importance of engaging with the research community. If you’re interested, you can read the interview in:

Thank You

As OA continues to grow around the world, events such as the MDPI Canada Summit remind us of the importance of meeting with our academic community in person. Listening to feedback, exchanging ideas, and building relationships are essential to ensuring that MDPI continues to evolve alongside the researchers, editors, reviewers, and institutions we serve.

Impactful Research

Five Journals, Five Different Stories of Success

Each year, the release of the Journal Citation Reports (JCR) provides an opportunity to look at the progress of our journal portfolio and, more importantly, the achievements of the research communities behind it.

A recent MDPI Blog article from Tommy Lax (Content Specialist, MDPI) highlights five journals whose 2025 Journal Impact Factor results show that success can take many forms –  from achieving a first Impact Factor, to steady long-term growth, to leadership within highly competitive disciplines.

The featured journals include:

  • Machine Learning & Knowledge Extraction (MAKE) – Among the 330 MDPI journals which received an Impact Factor in 2025, MAKE (ISSN 2504-4990) holds the accolade of having the highest rating of 8.4. The journal, which provides an advanced forum for the study of machine learning and its applications, is placed in Q1 for three subject categories: Computer science, artificial intelligence; Computer science, interdisciplinary applications; and Engineering, electrical & electronic.
  • Antioxidants – Continuing its strong position across multiple scientific disciplines, Antioxidants (ISSN 2076-3921) was awarded an exceptional Impact Factor of 8.2. In addition, the journal was placed in Q1 in three subject categories: Biochemistry & molecular biology; Chemistry, medicinal; and Food science & technology.
  • Biomass – This year, Biomass (ISSN 2673-8783) was recognized in the JCR for the first time, with a strong debut Impact Factor of 6.7. What makes this achievement even more impressive is the journal’s placement in Q1 of the category Engineering, chemical.
  • Analytica – Remaining with the theme of growth, Analytica (ISSN 2673-4532), which provides an advanced forum for all aspects of fundamental and applied analytical chemistry, recorded one of the largest year-on-year increases in Journal Impact Factor, with a 7.4 – an astounding 3.8-point increase from its 2024 rating of 3.6.
  • Batteries – Indexed in SCIE, Batteries (ISSN 2313-0105) received an updated Impact Factor of 6.3 this year, representing an increase of 1.5 versus last year, demonstrating consistent growth and increasing visibility over several years.

While citation metrics provide one perspective on journal performance, they tell only part of the story. Every milestone reflects the dedication of Editors-in-Chief, Editorial Board Members, reviewers, authors, and colleagues across MDPI who work together to uphold rigorous editorial standards and support high-quality research.

As a signatory of the Declaration on Research Assessment (DORA), MDPI supports a balanced approach to research evaluation. Journal-level metrics should be viewed alongside article-level indicators and the broader scientific and societal impact of published research.

Thank you to everyone whose commitment continues to strengthen our journals and advance Open Access across the global research community.

Inside MDPI

Building Better Tools for the Research Community: The Relaunch of Sciforum

Innovation at MDPI extends beyond journals. Over the past decade, we have continued to invest in products that support researchers, conference organizers, editors, reviewers, and institutions throughout the research lifecycle. As part of this ongoing investment, our Product and Engineering teams have been modernizing several of MDPI’s digital platforms. One important milestone in that journey is the relaunch of Sciforum, our conference management platform.

Read More: Sciforum Relaunch: Empowering Science through Seamless Event Management

Rather than simply updating an existing system, our product and engineering teams have rebuilt Sciforum, using a modern architecture designed to improve the user experience, support future growth, and continue to strengthen our position in the conference management market.

“Scalable technology is essential to delivering a high-quality experience”

Why We Rebuilt Sciforum

Technology must continue evolving alongside the needs of our users. The previous platform had served MDPI well for many years but had become difficult to extend and maintain. The new platform introduces a modular architecture that enables faster development, more flexibility, and a scalable foundation for future work.

Major improvements include:

  • Simplified submission workflows
  • Role-based dashboards
  • A modern website builder
  • Flexible pricing options
  • Permanent data hosting
  • A scalable architecture for future development

 

Supporting Our Conference Community

Sciforum is more than a software platform: it supports researchers, conference organizers, reviewers, speakers, and attendees by helping them organize, participate in, and share scientific meetings more efficiently. As MDPI continues to expand its conference activities worldwide, investing in modern, scalable technology is essential to delivering a high-quality experience for both our external partners and our internal teams.

Looking Ahead

The relaunch represents the beginning Sciforum’s next chapter. Planned improvements include: the Program Builder, Communication Hub, expanded payment options, Zoom integration, and a mobile application. These will continue to enhance the platform over the coming months.

Coming Together for Science

Highlights from ISPRS Congress 2026 – Toronto, Canada

In early July, I had the pleasure of attending the XXV ISPRS Congress in Toronto, one of the world’s leading gatherings for the geospatial and remote sensing research community. It was a great opportunity to meet researchers, editors, society leaders, and collaborators, while gaining insights into some of the latest developments in geospatial science and technology. 

Over several days, I had the privilege of presenting the Jack Dangermond Award; speaking about MDPI’s approach to AI in publishing and our 30-year journey in Open Access publishing; participating in Editorial Board meetings; and engaging with members of the ISPRS community. 

Below is a summary of these activities:

Celebrating excellence in research

One of the highlights of the week was presenting the Jack Dangermond Award for the best paper published in the ISPRS International Journal of Geo-Information (IJGI). Sponsored by MDPI and ESRI, the award recognizes an outstanding paper published over a four-year period and includes an ISPRS certificate together with a USD 10,000 prize.

Awards such as these remind us that journals are much more than publication platforms: they celebrate research that advances knowledge, inspires future work, and delivers meaningful impact for both science and society.

Presentations at ISPRS

I also had the pleasure to give two presentations during the congress:

1. The AI Revolution in Publishing: Challenges, Innovations, and MDPI’s Vision

The development of AI continues to transform scholarly publishing. During this session, I shared how MDPI is integrating AI responsibly, not to replace editorial judgement or peer review, but to support our staff by improving efficiency while maintaining scientific quality and research integrity.

2. MDPI: 30 Years of Open Access Publishing

I also had the opportunity to share MDP’s 30-year journey from a small publishing initiative to becoming a global Open Access publisher serving millions of researchers worldwide. As part of this session, my colleague Carla Aloè (Head of Societies and Acquisitions) introduced the ISPRS International Journal of Geo-Information (IJGI), sharing its development and contribution to the geospatial research community.

Meeting with Our Editorial Boards

Another rewarding aspect of the congress was meeting with the Editorial Boards of two of our journals:

  • Remote Sensing
  • ISPRS International Journal of Geo-Information

These discussions went beyond journal metrics. We heard ideas about editorial quality and emerging research areas, and we discussed reviewer engagement, diversity within editorial boards, and how journals can continue serving their communities for the future. These conversations are a great way to connect directly to the scientists who help shape our journals.

“One of our core missions has always been to make high-quality research openly accessible”

Partnerships matter

Scientific publishing is built on collaboration. Throughout the congress, our team welcomed researchers to the MDPI booth, met with authors and editors, and discussed opportunities for collaboration across our journals and society partnerships.

Special thanks to our MDPI colleagues who were present throughout the ISPRS congress supporting our Editorial Board meetings and the MDPI booth: Andy Tran, Carla Aloè, Carlo Cunanan, Diana Ribeiro Tosato, and Elena Duan.

Thank you to ISPRS for organizing this congress, to the researchers who shared their work, to our Editorial Board members, and to MDPI colleagues whose dedication continues to shape the journals and communities we support.

Closing Thoughts

Insights Into 30 Years of Impactful MDPI Research

As we celebrate 30 years of MDPI, it’s worth reflecting on the impact that the research we publish has on society. One of our core missions has always been to make high-quality research openly accessible so that it can inform new discoveries, public policy, education and innovation around the world.

A recent article on the MDPI Blog highlights several examples of MDPI publications that have gone beyond academic citations to help inform governments, international organizations and public policy discussions.

Research Creating Real-World Impact

The MDPI blog article features research that has contributed to topics including:

  • protecting the Amazon rainforest through satellite mapping
  • understanding climate change and urban heat inequality
  • encouraging more young women to pursue STEM careers
  • tackling obesity through healthier food environments
  • shaping sustainable urban planning through the “15-minute city” concept

These examples remind us that publishing research is not only about producing articles: it is about helping knowledge reach the people who can use it to improve lives and address global challenges.

Thirty Years of Open Access

MDPI’s 30th Anniversary is also an opportunity to recognize the collective contribution of everyone across MDPI. Every manuscript processed, every review coordinated, every system developed, every conference organized, every partnership established and every article published contributes to a much larger purpose: helping scientific knowledge move further and faster.

You can explore the full article here: 30 Years of Impactful MDPI Research

You can also visit our 30th Anniversary page to learn more about MDPI’s journey over the past three decades.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 August 2026
Interview with Dr. Federico Pio Fabrizio—Winner of the Journal of Personalized Medicine Young Investigator Award


1. Could you briefly introduce yourself and tell us about your current research interests?

I am Federico Pio Fabrizio, associate professor of Molecular Biology at the “Kore” University of Enna in Italy. My research career has focused primarily on understanding the molecular mechanisms underlying the development, progression, and treatment resistance of cancer, with a particular interest in lung cancer. My current research integrates epigenetics, molecular oncology, and precision medicine. In particular, I investigate DNA methylation alterations as predictive and prognostic biomarkers in solid tumors, with a particular focus on lung cancer and liquid biopsy approaches. I also study oncogenic signaling pathways, including the KEAP1/NRF2 and NRG1/ErbB3 pathways, to identify the mechanisms involved in tumor evolution and resistance to targeted therapies and immunotherapies. A central goal of my research is to translate molecular discoveries into clinically useful biomarkers capable of improving patient stratification and personalized treatment strategies.

2. What does receiving this award mean to you, both personally and professionally?
Receiving this award is a significant recognition of the commitment and dedication I have shown throughout my scientific career. For me, it is not only a recognition of my past achievements but also an incentive to continue pursuing innovative research paths. From a professional standpoint, this award underscores the importance of interdisciplinary approaches that combine molecular biology, genomics, epigenetics, and clinical oncology. On a personal level, it marks a significant milestone, especially given the challenges that early career researchers face in establishing independent scientific paths. I hope this award will also serve as a source of inspiration for young scientists who are charting their own research paths.

3. How did you hear about this award, and how supportive might this kind of award be for researchers?
I learned about the award through the scientific community and the activities promoted by the Journal of Personalized Medicine. Awards for early career researchers are extremely valuable because they offer visibility and recognition at a crucial stage of academic development. Beyond financial support, these initiatives help young researchers build confidence, expand their collaborations, and strengthen their scientific networks. Recognition from the scientific community can be a powerful motivator to continue pursuing ambitious research goals.

4. What originally inspired you to pursue a career in research and academia?
My motivation stemmed from the opportunity to understand the molecular mechanisms underlying human diseases and to translate that knowledge into more effective diagnostic and therapeutic strategies. During my early training in medical biotechnology, I was fascinated by the way genetic and epigenetic alterations influence cancer biology. This curiosity guided my decision to pursue a PhD and, subsequently, to continue my career in academic research. I was particularly drawn to the dynamic nature of science: every discovery raises new questions, and answering these questions requires continuous learning, collaboration, and innovation.

5. What have been some of the biggest challenges you have faced as an early career researcher, and how did you overcome them?
One of the main challenges has been to establish scientific independence while working in a highly competitive and rapidly evolving field. Early career researchers must balance experimental work, publication requirements, grant applications, teaching commitments, and the development of collaborations. I overcame these challenges through perseverance, continuous professional development, and collaboration with experienced researchers from national and international institutions. I firmly believe that scientific growth is fueled by teamwork, mentorship, and the ability to adapt to new technologies and concepts.

6. In your opinion, what are the most exciting developments or emerging trends currently shaping the field of your research?
The integration of multi-omic approaches represents one of the most exciting developments in cancer research. The combination of genomics, epigenomics, transcriptomics, and spatial biology provides unprecedented insights into tumor heterogeneity and resistance to therapies. In the case of lung cancer, I believe that liquid biopsy, particularly the profiling of circulating tumor DNA methylation, represents a promising avenue for early diagnosis, monitoring of minimal residual disease, and assessment of treatment response. Furthermore, the integration of artificial intelligence with molecular data could significantly improve biomarker identification and personalized oncology.

7. Are there any research questions or projects that you are especially excited to explore in the coming years?
I am particularly interested in understanding how epigenetic alterations contribute to tumor evolution and treatment resistance. I am also interested in exploring the interaction between epigenetic regulation and immune responses, including how chromatin remodeling and RNA modifications influence the outcomes of cancer immunotherapy.

8. Could you tell us about your experience with Journal of Personalized Medicine (JPM, ISSN 2075-4426) either as an author, reviewer, editor, or reader?
My experience with the Journal of Personalized Medicine has been very positive. I have contributed to the scientific community through manuscript review and have followed the journal as a platform for research focused on personalized medicine and translational science. The journal provides an important forum for studies that link molecular discoveries to clinical applications, which is perfectly aligned with my research interests in biomarkers and precision oncology.

9. What role do you think scientific journals such as JPM play in advancing research and fostering scientific exchange within the community?
Scientific journals play a fundamental role in disseminating knowledge, validating discoveries, and promoting scientific debate. Journals dedicated to personalized medicine are particularly important because they serve as a bridge between basic research and clinical applications. They facilitate the exchange of ideas among researchers, physicians, and multidisciplinary teams, accelerating the translation of discoveries into improved patient care.

10. What advice would you give to graduate students, postdoctoral researchers, and other young scientists who are at the beginning of their academic careers?
My advice is to remain curious, tenacious, and open to learning. Scientific careers are built over time and require dedication, resilience, and continuous improvement. Young researchers should develop strong technical expertise, but also cultivate critical thinking, communication skills, and international collaborations. It’s important to remember that every experiment. including those that fail, contributes to scientific progress. Finally, a passion for science is essential because it provides the motivation needed to overcome challenges and pursue meaningful discoveries.

11. Finally, do you have any suggestions on how JPM could further support young researchers and the academic community?
Journals such as JPM can further support early-career researchers by expanding initiatives such as early career awards, mentoring opportunities, dedicated editorial programs, and platforms that facilitate scientific networking. Encouraging early-career researchers to participate in peer review, editorial initiatives, and scientific discussions can help shape the next generation of researchers. I believe that supporting early career scientists is an investment in the future of biomedical research!

3 August 2026
Journal of Personalized Medicine | Editor’s Choice Articles in Q2 of 2026


We are delighted to share some of the Editor’s Choice Articles published in the Journal of Personalized Medicine (JPM, ISSN 2075-4426) in Q2 of 2026. The full list can be viewed via the following link: https://www.mdpi.com/journal/jpm/editors_choice.

1. “Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care”
by William Evans, Eric M. Meslin, Joe Kai and Nadeem Qureshi
J. Pers. Med. 2024, 14(4), 418; https://doi.org/10.3390/jpm14040418
Available online: https://www.mdpi.com/2075-4426/14/4/418
Cited by 30+ | Viewed by 13790+

2. “Long-Term Perspectives on Chronic Rhinosinusitis with Nasal Polyps: Evaluating Recurrence Rates after Functional Endoscopic Sinus Surgery in the Biologics Era—A 5-Year Follow-Up Study”
by Carlo Cavaliere, Simonetta Masieri, Elona Begvarfaj, Antonella Loperfido, Silvia Baroncelli, Francesca Cascone and Andrea Ciofalo
J. Pers. Med. 2024, 14(3), 297; https://doi.org/10.3390/jpm14030297
Available online: https://www.mdpi.com/2075-4426/14/3/297
Cited by 26+ | Viewed by 10035+

3. “Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?”
by Laura Calabrese, Martina D’Onghia, Laura Lazzeri, Giovanni Rubegni and Elisa Cinotti
J. Pers. Med. 2024, 14(7), 775; https://doi.org/10.3390/jpm14070775
Available online: https://www.mdpi.com/2075-4426/14/7/775
Cited by 25+ | Viewed by 8875+

4. “Severity and Clinical Outcomes of Pediatric Burns—A Comprehensive Analysis of Influencing Factors”
by Alexandra Toma, Dragoș Voicu, Constantin Popazu, Daniela Mihalache, Oana Duca, Dumitru Marius Dănilă and Dan Mircea Enescu
J. Pers. Med. 2024, 14(8), 788; https://doi.org/10.3390/jpm14080788
Available online: https://www.mdpi.com/2075-4426/14/8/788
Cited by 21+ | Viewed by 6585+

5. “The State of the Art in the Treatment of Actinic Keratosis and Field Cancerization: A Narrative Review”
by Andrea Paradisi, Enrico Bocchino, Maria Mannino, Giulio Gualdi, Alessandra D’Amore, Daniele Omar Traini and Ketty Peris
J. Pers. Med. 2025, 15(9), 421; https://doi.org/10.3390/jpm15090421
Available online: https://www.mdpi.com/2075-4426/15/9/421
Cited by 7+ | Viewed by 5480+

6. “Behavioural Cardiology: A Review on an Expanding Field of Cardiology—Holistic Approach”
by Christos Fragoulis, Maria-Kalliopi Spanorriga, Irini Bega, Andreas Prentakis, Evangelia Kontogianni, Panagiotis-Anastasios Tsioufis, Myrto Palkopoulou, John Ntalakouras, Panagiotis Iliakis, Ioannis Leontsinis et al.
J. Pers. Med. 2025, 15(8), 355; https://doi.org/10.3390/jpm15080355
Available online: https://www.mdpi.com/2075-4426/15/8/355
Cited by 6+ | Viewed by 2030+

7. “The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature”
by Aristi Boulmpou, Andreas Giannopoulos, Christodoulos Papadopoulos, Georgios Giannopoulos, Ioannis Papagiannis, Georgios Zormpas, Anastasia Keivanidou, Liana Fidani and Vassilios Vassilikos
J. Pers. Med. 2025, 15(3), 105; https://doi.org/10.3390/jpm15030105
Available online: https://www.mdpi.com/2075-4426/15/3/105
Cited by 6+ | Viewed by 6945+

8. “Artificial Intelligence in Adult Cardiovascular Medicine and Surgery: Real-World Deployments and Outcomes”
by Dimitrios E. Magouliotis, Noah Sicouri, Laura Ramlawi, Massimo Baudo, Vasiliki Androutsopoulou and Serge Sicouri
J. Pers. Med. 2026, 16(2), 69; https://doi.org/10.3390/jpm16020069
Available online: https://www.mdpi.com/2075-4426/16/2/69
Cited by 5+ | Viewed by 3090+

9. “Beyond Standard Parameters: Precision Hemodynamic Monitoring in Patients on Veno-Arterial ECMO”
by Debora Emanuela Torre and Carmelo Pirri
J. Pers. Med. 2025, 15(11), 541; https://doi.org/10.3390/jpm15110541
Available online: https://www.mdpi.com/2075-4426/15/11/541
Cited by 5+ | Viewed by 3310+

10. “Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities”
by Michael J. Hochman, Joshua P. Muniz and Nikolaos Papadantonakis
J. Pers. Med. 2025, 15(2), 49; https://doi.org/10.3390/jpm15020049
Available online: https://www.mdpi.com/2075-4426/15/2/49
Cited by 4+ | Viewed by 3130+

11. “Recent Insights into Organoid-Derived Extracellular Vesicles and Their Biomedical Applications”
by Ahmed Abdal Dayem, Yeonjoo Kwak, Hyemin Jeun and Ssang-Goo Cho
J. Pers. Med. 2025, 15(10), 492; https://doi.org/10.3390/jpm15100492
Available online: https://www.mdpi.com/2075-4426/15/10/492
Cited by 6+ | Viewed by 3940+

12. “Current Approaches to the Management of Rheumatic Diseases in Pregnancy: Risk Stratification, Therapeutic Advances, and Maternal–Fetal Outcomes”
by Aikaterini-Gavriela Giannakaki, Maria-Nektaria Giannakaki, Anastasia Bothou, Konstantinos Nikolettos, Nikolaos Machairiotis, Kalliopi I. Pappa and Panagiotis Tsikouras
J. Pers. Med. 2025, 15(9), 406; https://doi.org/10.3390/jpm15090406
Available online: https://www.mdpi.com/2075-4426/15/9/406
Cited by 5+ | Viewed by 3055+

13. “Pericapsular Nerve Group (PENG) Associated with Lateral Femoral Cutaneous Nerve (LFCN) Block Versus Fascia Iliaca Compartment Block (FICB) for Total Hip Replacement Surgery: Double-Blind Randomized Controlled Trial”
by Francesco Vetrone, Stefano Marelli, Andrea Galimberti, Michele Umbrello, Miriam Gotti, Angelo Pezzi and Alessandro Girombelli
J. Pers. Med. 2025, 15(6), 230; https://doi.org/10.3390/jpm15060230
Available online: https://www.mdpi.com/2075-4426/15/6/230
Cited by 6+ | Viewed by 3575+

14. “Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision Medicine”
by Alfonso Agüera-Sánchez, Emilio Peña-Ros, Irene Martínez-Martínez and Francisco García-Molina
J. Pers. Med. 2026, 16(1), 48; https://doi.org/10.3390/jpm16010048
Available online: https://www.mdpi.com/2075-4426/16/1/48
Cited by 4+ | Viewed by 2675+

15. “Biopsy-Driven Synovial Pathophenotyping in RA: A New Approach to Personalized Treatment”
by Sheyda Ketabchi, Edda Russo, Maurizio Benucci, Maria Infantino, Mariangela Manfredi, Emanuele Antonio Maria Cassarà, Francesca Li Gobbi, Alessandro Mannoni and Riccardo Terenzi
J. Pers. Med. 2025, 15(12), 622; https://doi.org/10.3390/jpm15120622
Available online: https://www.mdpi.com/2075-4426/15/12/622
Cited by 6+ | Viewed by 1765+

16. “Primary Tricuspid Regurgitation: From Neglect to Clinical Relevance”
by Mariagrazia Piscione, Jad Mroue, Dario Gaudio, Vivek Mehta and Fadi Matar
J. Pers. Med. 2025, 15(11), 535; https://doi.org/10.3390/jpm15110535
Available online: https://www.mdpi.com/2075-4426/15/11/535
Cited by 5+ | Viewed by 2275+

You can view the abovementioned articles and submit papers to JPM via the following link: https://www.mdpi.com/journal/jpm.

JPM Editorial Office

30 July 2026
Journal of Personalized Medicine | Summary of Academic Publishing Workshop at Aston University Held on 7 July 2026

MDPI, represented by Senior Deputy Managing Editor, Mary O’Sullivan, and Deputy Managing Editor, Amy Turner, was excited to collaborate with Dr. Jaimy Saif, Senior Lecturer at Aston University, United Kingdom. Together, they organized an Academic Publishing Workshop for professors and students at the university. This workshop aimed to provide attendees with a comprehensive understanding of the open access publishing landscape, clarify MDPI’s editorial processes, and offer practical guidance on publication ethics and manuscript preparation. The event was attended by 12 participants.

Event: Academic Publishing Workshop at Aston University with Journal of Personalized Medicine:

  • Organized by Dr. Jaimy Saif, MDPI UK and Journal of Personalized Medicine;
  • Date: 7 July 2026;
  • Location: Aston University Main Campus, Main Building, Ground Floor, Room G79;
  • Speakers: Mary O'Sullivan and Amy Turner;
  • Language: English;
  • Number of participants: 12 attendees.

This insightful event brought together experts in academic publishing to discuss key topics including open access, editorial workflows, and publication ethics.

The session began with an opening speech by Dr. Jaimy Saif, our Guest Editor of the Journal of Personalized Medicine (JPM, ISSN 2075-4426), who set a welcoming and professional tone for the gathering.

Following the introduction, Amy Turner presented on “The Benefits of Open Access Publishing and MDPI’s Editorial Process”. She highlighted the advantages of open access in expanding the reach of research and provided a comprehensive overview of MDPI’s rigorous and efficient editorial workflow.

Next, Mary O’Sullivan delivered an informative talk titled “Publication Ethics, Reasons for Manuscript Rejection, and How to Respond”. She emphasized the critical importance of maintaining ethical standards in academic publishing, analyzed common reasons for manuscript rejection, and offered practical, constructive advice on how authors can effectively respond to and address these challenges.

The presentations were followed by a short Q&A session co-hosted by Amy and Mary. They jointly addressed questions from the attendees, sparking an interactive and engaging discussion.

Overall, the event provided valuable insights into the open access publishing model and equipped participants with practical strategies to enhance their manuscripts and navigate the publication process successfully. 

  • Organizer: Dr. Jaimy Saif

Dr. Saif's background is in immunotherapy (from PhD studies) and therapeutic angiogenesis. Dr. Saif has worked on reparative angiogenesis in different labs in Ludwig Maximilian University of Munich in Germany, the Spanish National Cancer Research Centre in Spain, and the University of Nottingham and Nottingham Trent University in UK.

Dr. Saif joined the Vascular Regeneration Team, led by Prof. Asif Ahmed, at Aston University in 2018, researching etiology and developing new therapies for pre-eclampsia. She is a PhD scientist but most of her previous mentors were clinical academics, which helped her to participate in translational research to influence clinical practice. She currently works as a Senior Lecturer in Aston Medical School, leading the Cardiovascular and Respiratory System Blocks in Phase I of the MBChB Program at Aston Medical School. She also works as the Phase I Assessment Implementation Lead.

25 July 2026
Meet Us Virtually at The 2nd International Online Conference on Personalized Medicine (IOCPM 2027), 20–21 October 2027


We cordially invite you to attend this event organized by Journal of Personalized Medicine (JPM, ISSN 2075-4426; CiteScore 7.2; Indexed in PubMed). The conference will be held virtually from 20 to 21 October 2027, Central European Summer Time.

Conference Chair:

  • Prof. Dr. Kenneth P. H. Pritzker Professor Emeritus, Laboratory Medicine and Pathobiology; Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Topics of interest:
S1. Disease Mechanisms for Personalized Medicine;
S2. Personalized Diagnostics, Therapeutics, and Personalized Preventative Medicine;
S3. Pharmacogenomics, Multi-Omics, and Informatics for Personalized Medicine;
S4. Personalized and Precision Oncology.

Important dates:
Deadline for abstract submission:
18 June 2027;
Abstract acceptance notification: 20 August 2027;
Registration deadline: 14 October 2027.

Guide for Authors:
To submit your abstract, please click the following link: sciforum.net/submissions/IOCPM2027/1.

To register for the event, please click the following link: sciforum.net/registration/IOCPM2027/tickets.

For details regarding abstract submission, poster and slide submission, and publication opportunities, please refer to the “Instructions for Authors” section: https://sciforum.net/event/IOCPM2027/instructions-for-authors.

For any enquiries regarding the event, please contact iocpm@mdpi.com.

We look forward to welcoming you to the 2nd International Online Conference on Personalized Medicine.

15 July 2026
Summary of the MDPI Academic Publishing Workshop at the Congress of Specialty Chapters in Miami, Held on 13 June 2026


In collaboration with Dr. Andres M. Álvarez Pinzon, MDPI hosted an Academic Publishing Workshop during the Neurosurgery Symposium held from 11 to 15 June in Miami.

Held as part of the Congress of Specialty Chapters, the Neurosurgery Symposium was jointly organized by SLANC and FLANC under the leadership of Dr. Jose Valerio (Chairman of the Neurosurgical Oncology Section, WFNS). The event brought together approximately 100 neurosurgeons, specialists, and residents.

Representing MDPI, Ms. Bianca Raluca Berezoschi led two focused sessions: Academic Writing Techniques and Publication Ethics. These sessions provided attendees with essential skills for manuscript preparation and navigating the ethical standards of medical publishing.

Event: Academic Article—Writing Techniques in Neurosurgery and Neurosciences

Publication Ethics

  • Organizer: Congress of Speciality Chapters;
  • Date & Time: 13 June, 2:00 p.m. EST;
  • Location: Online;
  • Language: English;
  • Organized by Dr. Andres M. Álvarez Pinzon;
  • Lecturer: Ms. Bianca Raluca Berezoschi;
  • Audience: participants of the Congress of Speciality Chapters;
  • Number of participants: ~100;
  • The project had two sessions: Academic Writing Techniques and Publication Ethics.

The presentation covered the full lifecycle of academic publishing, starting with journal selection. We discussed how to evaluate journals based on aim and scope alignment, Impact Factor, quartile ranking, article processing charges (APCs), and indexing databases while introducing MDPI's Journal Finder tool as a practical resource. The session then covered manuscript structure, detailing the front matter, main text, and back matter, along with concrete guidelines for each section.

The presentation then moved to publication ethics, framing it as central to scientific integrity and public trust. It outlined the main forms of author misconduct in order of severity: data falsification (most frequent), plagiarism—including self-plagiarism (most detectable)—ethical violations involving human or animal subjects (most serious), duplicate publication, salami slicing, undisclosed conflicts of interest, and authorship abuse (such as ghost, guest, or gift authorship). We also discussed the use of tools such as iThenticate and internal screening software, alongside COPE and ICMJE guidelines, to investigate and resolve ethical issues.

Additionally, the session addressed the evolving role of artificial intelligence in research. The presentation concluded with an interactive Q&A, where participants sought further guidance on funding options for APCs and the editorial handling of undisclosed AI use in manuscripts.

Organizer:

Dr. Andres M Álvarez Pinzon, Neurosurgical Oncology & Vascular Neurology Director of Innovation and Research Latino America Valerio Foundation Vice Chair, Developmental Therapeutics Committee, NRG Oncology (NCI) Member, Brain Tumor Committee, NRG Oncology Associate Professor, School of Medicine, Florida Atlantic University.

8 July 2026
MDPI’s Newly Launched Journals in June 2026


Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In June 2026, eleven new journals released their inaugural issues and two transferred journals released their first issue as part of MDPI, covering the subjects of environmental & earth sciences, chemistry & materials science, public health & healthcare, engineering, medicine & pharmacology, and biology & life sciences. 

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, enabling impactful open access scholarship. 

Please feel free to browse and discover more about the new journals below. 

New Journals

Founding Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Xiaochuan Pan,

Peking University, China

Editorial | view inaugural issue

public health research, practice, policy, and education; eco-health equity |

view journal scope | submit an article

Prof. Dr. Xin-Gao Gong

Fudan University, China;

Prof. Dr. Zhimei Sun

Beihang University, China

Editorial | view inaugural issue

AI-enhanced theory & simulation; generative design & discovery; autonomous experimentation; AI for characterization; large language models and agents |

view journal scope | submit an article

Prof. Dr. Yong Liu,

Wuhan University, China

Editorial | view inaugural issue

hydropower technology; renewable energy; water resources; optimization; rock and soil mechanics; power system stability |

view journal scope | submit an article

Prof. Dr. Giovanni Rezza,

University Vita-Salute San Raffaele, Italy

Editorial | view inaugural issue

pandemic preparedness; public health; global outbreak dynamics and epidemiology; outbreak prediction and risk forecasting; one health approach; zoonotic and pre-pandemic vaccines |

view journal scope | submit an article

Prof. Dr. Brian Horton,

University of Texas at Austin, USA

Editorial | view inaugural issue

stratigraphy; sedimentology; earth surface processes; basin evolution and tectonics; climate and paleoclimate |

view journal scope | submit an article

Prof. Dr. Yike Guo,

Hong Kong University of Science and Technology, China

Editorial | view inaugural issue

artificial intelligence (AI); application of AI to engineering; Explainable AI (XAI); AI-driven design and optimization; AI for manufacturing and automation | view journal scope | submit an article

Prof. Dr. Hei Wong,

City University of Hong Kong, China

Editorial | view inaugural issue

novel semiconductor materials; advanced heterogeneous integration technologies; advanced characterization and testing techniques; heterogeneously integrated systems and applications; modeling and design automation|

 view journal scope | submit an article

Prof. Dr. Michail Panagiotidis,

Mississippi State University, USA

Editorial | view inaugural issue

plant-based medicines; natural products-based drug discovery; plant-based bioactive compounds; pharmacognosy; phytochemicals; pharmacokinetics |

view journal scope | submit an article

Prof. Dr. Khalid Meksem,

Southern Illinois University, USA

Editorial | view inaugural issue

genome biotechnology; applied genomics; genetic engineering; agricultural biotechnology; medical biotechnology; data science and AI|

view journal scope | submit an article

Dr. Chenxi Wu,

Chinese Academy of Sciences, China

Editorial | view inaugural issue

environmental cleanup; ecological restoration; environmental management and governance; environmental modeling and monitoring |

view journal scope | submit an article

Prof. Dr. Janusz Kozinski,

Lakehead University, Canada

Editorial | view inaugural issue

renewable energy; sustainable agriculture; green innovation; climate change; artificial intelligence and environmental sustainability |

view journal scope | submit an article

Transferred Journals

Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Thomas Frese,

Martin-Universität Halle-Wittenberg, Germany

Editorial | view first issue

health services in primary care; integrated care models; quality and safety of care; coordination across primary and secondary care services; patient management; primary care clinical practice and interventions; clinical interventions delivered in primary care settings;

view journal scope | submit an article

Prof. Dr. Paul Gerson Unschuld,

Geneva University Hospitals (HUG), Switzerland

Editorial | view first issue

neurology, psychiatry, psychotherapy, and the neurosciences |

view journal scope | submit an article

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

8 July 2026
Honoring the Top 1000 Reviewers for 2025


Peer review is the invisible foundation of academic progress. The 2025 MDPI Top Reviewers are some of the key experts who helped build it.

We are honored to recognize 1000 individuals from our global community of 210,000 reviewers across 67 countries and territories—chosen for their commitment to rigorous, constructive peer review and the consistency of their contributions throughout 2025.

The Top Reviewers provided constructive and impartial feedback that makes research stronger and more impactful, and we are grateful for it.

The names of these reviewers are listed below in alphabetical order by first name:

A. N. M. Mamun-Or-Rashid

Han Wu

Nijia Qian

Abdallah Galal

Hani Nasser Abdelhamid

Nikola Petrović

Abdeljabbar Ghanmi

Hanstter Rezende

Nina Mendez-Dominguez

Abdelmalek Bellal

Han-Tsung Wang

Nora Ahmed

Abdelnasser Abidli

Hao Tang

Nurcan Kilinc-Ata

Abderrahim Ayad

Haodong Chen

Oğuzhan Çetindemir

Abdulkadir Atalan

Haoxuan Dong

Oksana Kovtun

Abid Ullah

Hassan Barakat

Oluwagbemiga Paul Agboola

Adeney De Freitas Bueno

Hassan Harb

Omar Alsetoohy

Agnieszka Synowiec

Hebat-Allah Sarhan Tohamy

Ömer Kaya

Agnishwar Girigoswami

Héctor Mora-Montes

Omneya Attallah

Agustín Ariño

Hengkai Li

Orestis M. Ioannidis

Ahmadjan Muhammadhaji

Hengrui Liu

Oscar Arias-Carrion

Ahmadreza Mohebbi

Hiroshi Matsuyama

Osmar Antonio Jaramillo Morales

Ahmed Gad

Ho Namgung

Palash Mandal

Ahmed Ghezal

HoangNam Tran

Panayiotis Iliakis

Ahmed Mohamed Nabil Helaly

Hongfen Zhu

Pargam Vashishtha

Ahmed Saad Rashed

Hongzhi Shen

Parisa Kaviani

Ahmet İhsan Turan

Hossein Lotfi

Patrycja Kleczkowska

Aidin Bordbar-Khiabani

Huajin Li

Paula Pinto

Alain Manuel Chaple Gil

Huayue Chen

Paulius Skačkauskas

Alan Gasiński

Hui Lu

Paulo Cezar Bastianello Campagnol

Albena Doicheva

Huseyin Cetin

Pavel Kic

Alberto Gallegos

Hyeong-Geun Kim

Pavlo Maruschak

Alejandro Cano-Villagrasa

Hyoungchul Shin

Paweł Ciężkowski

Aleksandr Bobrovskikh

Ibrahim Mohamed

Paweł Rydzewski

Aleksandra Figurek

Ibrahim Mosly

Pedro Valdivia-Moral

Aleksandra Jovanović

Ibtissam Bakkouri

Peng Chen

Aleksandra Rybak

Igor Schepetkin

Pengle Cheng

Alessandro Poggi

Ilias Lazos

Philippe Colomban

Alessio Castagnoli

Imen Barraj

Pier Nicola Sergi

Alexandre Pimenta

Imran Ali

Ping Zhu

Alexey Andreychev

Imtiaz Ahmad

Piotr Legutko

Alexey Beskopylny

Ioannis A. Giantsis

Piotr Lichota

Alexis Murillo Carrasco

Ioannis Vardiambasis

Poya Sohrabi

Alfredo Teixeira

Irina Georgescu

Pradeep Kumar Yadav

Ali Abd El-Aty

Isaac Adejumo

Prashant Singh

Ali Alshebami

Isabel Legaz

Prithviraj Nandigrami

Ali Ercetin

Isabel Maldonado

Przemysław Podulka

Ali Kandil

Isabel Marques

Qiang Peng

Alireza Shoari

Itamar Luís Gonçalves

Qiang Yao

Alok Tiwari

Ivan Laktionov

Qiaochu Li

Aman Muhammad

Ivan Šoša

Qichang An

Amgad Fahmy

Ivan V. Semenyuta

Qingqing Sun

Amira Mohamed Idrees

Izabela Zakrocka

Rabii El Maani

Amr Mohamed

Jae Hwan Lee

Radosław Balwierz

Amroune Salah

Jakub Ciazela

Rafat Ghanamah

Anastasia Ivanova

Jale Minibas-Poussard

Rajaram Rajamohan

Anastasios Koulaouzidis

Jamal Ayour

Rajendra Rohokale

Anatoli Popov

James A. Bunce

Raluca Isac

András Molnár

Janvier Habumugisha

Raluca Mureşan

André Luiz Missio

Jarogniew Łuszczki

Ramalingam Manikandan

André Pinto

Jasna Čanadanović Brunet

Rashad EL-Sagheer

André Rolim Baby

Jean-Louis Pinault

Rashid Dallaev

Andres Camargo-Sanchez

Jelena Petrović

Ravish Patel

Andrew Perry

Jesús Bernardo Páez-Lerma

Rehan Jamil

Andrey Kuskov

Jesus Jaquez-Muñoz

Renzo Pepe-Victoriano

Andrey Zamyatnin

Jia Wang

Ricardo Hernández-Martínez

Andrii Velychkovych

Jia Wen Li

Ricardo Luiz Fernandes Bella

Angeliki Papalou

Jia-Bin Wu

Ricardo Raimundo

Anita Sejben

Jianfeng Chen

Rina Zviel-Girshin

Anja Terzić

Jiangmin Ding

Ritthideach Yorsaeng

Anna Kamenskikh

Jiangxiong Zhu

Robinson J. Herrera-Feijoo

Anna Maria Kot

Jiangyu Zhu

Rocco Ditommaso

Antanas Laurincikas

Jianhua Ren

Rocco Vitis

Anton Tkachenko

Jianjian Zheng

Rodrigo Valenzuela

António Miguel Monteiro

Jianzhao Qi

Roman Dmytryshyn

António Portelada

Jiazhen Zhang

Roman Parovik

Antonios Christou

Jifu Li

Ronit Sionov

Antreas Kantaros

Jingcai Zhang

Ruben Rodríguez Elizalde

Arash Kardani

Joanna Kosałka-Węgiel

Ružica R. Nikolić

Arash Shams Taleghani

João Carlos Caetano Simões

Sadegh Ghaderi

Armand Faganel

Jonathan Soldera

Salih Özer

Artem Perepelitsyn

Jongbeom Lim

Saliha Karadayi-Usta

Ashraf Ali

Joon Hyuk Choi

Salvatore Falanga Bolognesi

Asif Ali Haider

Jorge L. Mejía-Méndez

Salvatore Simone

Atila Kumbasaroglu

José Ascención Martínez Álvarez

Sandeep Kumar Chamoli

Aurel Burciu

José Antonio Suarez-Navarro

Sandra Pascual-García

Aynur Aliyeva

José Carlos Vázquez-Parra

Sanjin Kovacevic

Ayushman Ramola

Jose Lavres Junior

Santiago Juan-Navarro

Azizollah Khormali

José Leija-Martínez

Santosh Reddy Addula

Baishu Guo

José Luis Aguirre-Noyola

Saravanan Ramasamy

Baoqiang Liu

José Ramiro Fernandes

Sasa Radoslav Bubanj

Bartłomiej Zieniuk

José Rodrigues

Saurabh Agarwal

Bartosz Kruszewski

Josef Yayan

Sayed Saber

Beata Dedicova

Juan Gabriel Avina-Cervantes

Sebastian Schnaubelt

Behnam Mobaraki

Juan Sebastián Fernández-Prados

Sergei G. Gaidin

Ben Ingram

Juan Vielma-Perez

Sergii Sagin

Bernardo Tutikian

Jui-Hsiang Lee

Serife Balikci

Bhupinder Kumar

Junhe Yu

Seweryn Lipiński

Biao Luo

Jun-Sheng Zhang

Shadfar Davoodi

Bin Wang

Justin Nnaemeka Onyeukaziri

Shamsaldeen Ibrahim Saeed

Bin Yan

K. S. Anandh

Shanmugam Vignesh

Binfeng Yin

Kaibing Zhou

Shaohua Lei

Bing He

Kakarla Ramakrishna

Sheng Chang

Bingnan Guo

Kamil Henryk Nelke

Shengqun Deng

Bingzhe Zhang

Kamran Shah

Shigeru Kanemitsu

Bishal Baniya

Karina Teixeira Magalhães-Guedes

Shijun Pan

Bojan Stojanovic

Karol Chilmon

Shiquan Wang

Bojana S. Stojanovic

Karthik Kannan

Shiva Shankar Reddy

Bojana Vidovic

Kasireddy Sudarshan

Shuai Yuan

Bozena Gajdzik

Katarzyna Mądra-Gackowska

Shun Yao

Byoungwook Ahn

Kavipriya Thangavel

Shuo Liu

Caio Santos Bonilha

Keith Watts

Siham Bakkouri

Carlos Cerdán Santacruz

Kelcie Slaton

Silviu Beciu

Carlos Marcuello Anglés

Kesavan Nair

Simone Galano

Carolin Hannusch

Ketan M. Ranch

Simone Treccarichi

Catalin Bulai

Khrystyna Lipianina-Honcharenko

Sina Sarfarazi

Cátia Sousa

Khursheed Ahmad

Sinan Chen

Changning Liu

Kinga Korniejenko

Sing-Chung Li

Chanin Khomlaem

Kiwon Lee

Sivakumar Jeyarajan

Chao Fu

Konrad Szychowski

Slađana Popović

Chao Zheng

Konstantin Alexandrovich Rybakov

Slavica Miladinovic

Chen Kim Lim

Konstantinos Arsenopoulos

Slobodanka Galovic

Cheng Fang

Koulla Parpa

Sofoklis Stavros

Cheng Li

Kun Yang

Somya Agrawal

Chengling Lu

Kuo-Chien Liao

Song Yu

Chenkang Liu

Lambert Zixin Li

Sotomi Ishihara

Chigozie Andy Ngwaba

László Orlóci

Stanisław Pietrzyk

Chih-Wei Zeng

Laura Diaconu Maxim

Stefanos Kourtis

Chin-Feng Lin

Laxman Subedi

Stepan Dzhimak

Ching-Ta Lu

Leilei Wei

Sudarshan Singh

Chunxiao Li

Leonidas Trakolis

Suhan Zhang

Corina Aurelia Zugravu

Liang Zheng

Süleyman Çınar Çağan

Costel Plescan

Lijana Maskeliūnaitė

Swati Dahariya

Cristian Ciobanescu

Liliya Demidova

Syed Asad Ali Zaidi

Cristina Dumitru

Lorena Del Carmen Espina Romero

Szymon Suwała

Dajun Liu

Lorentz Jäntschi

Tae Young Ko

Dan Valeriu Voinea

Luca Giacomelli

Tao Ni

Daniel Badulescu

Luciana Rotaru

Tarek Berghout

Daniel Miron Brie

Luis Miguel Pires

Tatiana Fedotcheva

Daniel Piotr Potaczek

Luis O. Viteri Jumbo

Tatiana V. Vygodina

Daniel Sanin-Villa

Lvyang Ye

Tetsuya Tanioka

Danijela Smiljanic

Maconi Teixeira

Theoharis Babanatsas

David Michel De Oliveira

Madina Isametova

Thomas Roule

Daxin Dong

Magdalena Pietrzak

Tiago Lima De Albuquerque

Dejan Ćirin

Mahendra Kumar Samal

Tiziana Maria Sirangelo

Dejan Vasovic

Mahmoud Owais

Tomáš Toporcer

Deju Zhang

Maja Hitl

Tomasz Koczorowski

Denis Stanescu

Maksim Iavich

Tomyslav Sledevič

Derya Arslan

Małgorzata Rataj

Tudor Sorin Pop

Di Tian

Manal Fawzy

Tuğba Kuru Çolak

Dignesh Khunt

Mansoor-Ali Vaali-Mohammed

Tuo Zeng

Dikshat Gupta

Manuel De La Sen

Tzu-Hurng Cheng

Dimitrios Doukas

Manuel Saba

Vahdettin Demir

Dimitrios Fanourakis

Manuele Cesare

Valdivino Domingos de Oliveira Júnior

Dina Khoudaer

Marcelo Kaminski Lenzi

Vanessa Bergamin Boralli

Dmitriy Tverdyi

Marcia Bastos Convento

Vasile Razvan Filimon

Dmitry Erokhin

Márcio Vargas-Ramella

Vasileios Greveniotis

Domenico Rosa

Marco Cavaco

Vasily Lubashevskiy

Dominika Gajdosikova

Marco Eigenfeld

Vasudeva Reddy Netala

Dominika Guzek

Marco Fogante

Vesselin Gueorguiev

Dong Wook Shin

Marco Vincenzo Valente

Vicente Borja Jaimes

Dong Zhao

Marcos Antonio Japiassu Resende Montes

Vicente González-Prida

Donghyun Lee

Marcus Goncalves

Victor Abiola Adepoju

Dongwang Wu

Marek Wozniak

Vidyasrilekha Sanapalli

Dongzhao Jin

María Guadalupe Frías-De-León

Vikas Mehta

Douglas Watts

Maria Pia Di Palo

Vilmar Steffen

Dragana Filipovic

Marian Palcut

Vincenzo Mirco La Fazia

Duc Hung Pham

Marianna Olivadese

Vincezo Cuteri

Dulani Meedeniya

Marielena Saivish

Virginia-Maria Rădulescu

Dumitru Toader

Marija R. Popović-Nikolić

Vlad Stoian

Dursun Zafer Seker

Marina Konuhova

Walaa Salah

Eber Quintana-Obregón

Marino Paroli

Walter R. Schumm

Eduarda Vieira

Marios Christodoulou

Wang Chun Kwok

Eduardo Alvarez-Duarte

Mariusz Bialecki

Weber Da Silva Robazza

Eduardo Fernandes

Marko Bašković

Wei Ling

Edwin M. Pino-Vargas

Marko Slavković

Wei-Biao Liao

Efraín Villamor Herrero

Massimo Pacella

Weichen Zhan

Ehab Ali

Matteo Angelo Fabris

Weiwei Han

Ehab AlShamaileh

Matteo Conti

Welson Bassi

Ehsan Hosseini

Matteo Pellegrini

Wen Chen

Ekaterina Lesovaya

Maurizio Sabbatini

Wiktor Stopyra

Elcio Ferreira Dos Santos

Maxim Polyakov

Wilhelm Londono

Elena Tchetina

Mazen Al-Kheetan

Wilhelm Mistiaen

Elina Margarida Ribeiro Marinho

Mehmet Das

William Aperador

Elnaz Amirahmadi

Mehmet Palanci

Wojciech Niemczyk

Eloy Conde

Melissa Anne Beryl Vogt

Xiang Lei

Elvira Rozhina

Menaouar Berrehil El Kattel

Xiang Zhang

Emad A. Az-Zo'bi

Meng Zhang

Xiangchen Meng

Emmanouil Georgios C. Tzanakakis

Michael Halim

Xiao Jian Tan

En Lu

Michal Stosiak

Xiaohai Zheng

Enrique Cervantes Pérez

Michał Zarobkiewicz

Xiaokang Ma

Eqram Rahman

Michele Paolantonio

Xiaoxi Hu

Erand Llanaj

Mika Merviö

Xin Li

Eungi Kim

Mikhail Akimov

Xin Yang

Evangelos Tsiaras

Mikhail Arbatsky

Xin Zhang (Henan Institute of Science and Technology)

Fabio Massimo Oddi

Mikhail Statkus

Xin Zhang (Tianjin Normal University)

Fahad Al Basir

Milan Lal

Xinfa Tang

Faïçal Brini

Milica Dimitrijevic Stojanovic

Xinxin Zhao

Fanglei Zhong

Miłosz Huber

Xinyan Peng

Faseeulla Mohammad

Ming Wu

Xu Li

Fayyaz Qureshi

Minh Tam Schlosky

Yang Shen

Fazlurrahman Khan

Mira Chitt

Yanlin Shi

Federico Minelli

Mirela Jimborean

Yanlong Ji

Fei Han

Mirela Lučan Čolić

Yasir Rasool

Fei Yu

Miriam González-Afonso

Yaxsier De Armas

Fekete Mónika

Mirjana Ocokoljić

Yew Hoong Wong

Fengwei Wang

Miroslava Rakocevic

Yile Chen

Fernando França Cunha

Mohamed A. Hassan

Yinbo Gan

Fernando Marson

Mohamed Ibrahem Elhawy

Yinghao Shan

Fernando Monroy

Mohamed-Amine Babay

Yixin He

Filipe Pereira

Mohammad Aldossary

Yong Zhang

Flaviu Mihai Frigură-Iliasa

Mohammad Ali Arjomand

Yonggang Kim

Florian Pape

Mohammad Mofatteh

Yoshiro Horai

Florin Oancea

Mohammad Nurul Matin

Younho Han

Francesco Cali

Mohammad Younis Hajeer

Youqiang Zhang

Francesco Gagliardi

Mohammed Abdulrasak

Yuan Chen

Francisco Delgado

Mohammed Alnaim

Yuanjie Deng

Francisco E. M. Silveira

Mohammed M. Gomaa

Yuchen Wang

Francisco Guillen-Grima

Mohd Ismail Ibrahim

Yue Cheng

Francisco Rafael Trejo-Macotela

Mohd Usman Mohd Junaidi

Yue Ma

Fredrick N. Eze

Moisés Tolentino Bento Da Silva

Yue Tan

Fredy Hoyos Velasco

Monika Michalska

Yufei Gao

Fuhaid Alshammari

Mostafa Shooshtari

Yunchao Tang

Gabriel Marín Díaz

Mothana Mustafa Gasaymeh

Yuniel Méndez-Martínez

Gabriel Sperandio Milan

Mubarak A. Alanazi

Yuri Tokarev

Gabriela Ignat

Mudasir Younis

Yurii Syromyatnikov

Gamal Ebrahim

Muhammad A. Butt

Yury V. Ilyushin

Gang Hui

Muhammad Jamil

Yuyan Pan

Gaydaa Al-Zohbi

Muhammad Munir

Zbigniew Raszewski

George Karabatsos

Muhammad Waseem

Zbigniew Waśkiewicz

Gerardo Fuentes-Vilugrón

Muntean Calin

Zeashan Khan

Gerasimos Pagiatakis

Murat Demiral

Zeesham Abbas

Giovani Telli

Mussa Makran

Zhao Li

Gleb Zaitsev

Mustafa Bora

Zhen Zhang

Golap Kalita

Mustafa Zeybek

Zheng Lu

Gonzalo Emiliano Aranda-Abreu

Muzaffar Iqbal

Zheng Yuan

Goran Marinkovic

Nafiu Olanrewaju Ogunsola

Zhengchang Wu

Guangliang Xing

Nagendra Verma

Zhenhua Zhang

Guanjun Yang

Nam Deuk Kim

Zhenyu Liu

Guanzhou Ji

Narayanaswamy Venketasubramanian

Zhiguo Meng

Guilherme Welter Wendt

Natalia Kurhaluk

Zhouli Liu

Guillermo Berumen-Varela

Natalija Čutović

Zhuofu Liu

Guna Sekhar Sajja

Natesan Thirumalaivasan

Zied Ben Hazem

Guojie Xie

Nebojša Jurišević

Zihan Qu

Hajer Ben Ammar

Nevien Elhawat

Zongwu Chen

Hamid Ghazi Sulimany

Nguyen Thi Thanh Binh

Zorica Mojović

Hamid Osman

Nicolás Amigo

(Note: we respected all privacy preferences, with part of nominees opting for limited attribution.)

6 July 2026
Meet Us at the ESC Congress 2026, 28–31 August 2026, Munich, Germany


A range of MDPI journals will be attending International Congress Center Messe München in Munich, Germany from 28 to 31 August 2026.

Furthermore, 2026 marks MDPI’s third year of partnering with ESC Congress. Centered on the theme “Spotlight on Artificial Intelligence”, the conference explores AI as an auxiliary clinical tool that improves accuracy, workflow speed and patient safety. More than 32,000 delegates joined last year’s event, and MDPI secured 122 valuable contacts on-site.

The following open access journals will be represented at the ESC Congress 2026:

If you are planning to attend the above conference, please do not hesitate to drop by our booth and start a conversation with us; we look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.escardio.org/Congresses-Events/ESC-Congress# or contact the Journal of Cardiovascular Development and Disease Editorial Office at jcdd@mdpi.com.

Back to TopTop